| Not Yet Recruiting | Sacituzumab Tirumotecan Plus Third-Generation TKI With/Without Radiotherapy for EGFR-Mutant NSCLC Brain Metast NSCLC (Advanced Non-small Cell Lung Cancer), EGFR Gene Mutations, Brain Metastasis | Phase 2 | 2026-05-01 |
| Recruiting | Safety and Efficacy of Umbilical Cord Blood Therapy for Cancer Therapy-Induced Thrombocytopenia (CTIT) Thrombocytopenia, Cancer Treatment-induced Thrombocytopenia | Phase 2 | 2026-02-28 |
| Recruiting | Thiotepa in Combination With Pirtobrutinib (a BTK Inhibitor) and Sintilimab (a PD-1 Inhibitor) for Frail or Re Pirtobrutinib, Sintilimab, Central Nervous System Lymphoma | Phase 2 | 2026-02-10 |
| Active Not Recruiting | Construction of a Predictive Model for the Efficacy of Chemoprevention Combined With Targeted Therapy in Pancr Pancreatic Cancer Resectable, Pancreatic Cancer Non-resectable | — | 2025-12-08 |
| Recruiting | A Phase II Clinical Study Evaluating Entinostat With or Without Anlotinib + Fulvestrant for the Treatment of H Breast Cancer | Phase 2 | 2025-11-24 |
| Recruiting | Firstline Sequential AG and mFOLFOX Combined With Serplulimab and Bevacizumab Versus AG Chemotherapy Alone in Non-Resectable Pancreas Carcinoma | Phase 3 | 2025-11-15 |
| Recruiting | Perioprative Study of IBI363 in Patients With MHC-II-Negative Locally Advanced Gastric Cancer IBI363 + Chemotherapy | Phase 2 | 2025-11-03 |
| Recruiting | An in Vivo CT Imaging Study of GMA-Tulip, I-gel, and LMA Supreme (GLAM-II) Supraglottic Airway Device | N/A | 2025-10-12 |
| Not Yet Recruiting | A Real-world Study on the Compliance of OFS-assisted Endocrine Therapy for Hormone Receptor-positive(HR+) Prem Breast Cancer Females | — | 2025-10-10 |
| Not Yet Recruiting | Study on Safety and Efficacy of UCB-MNCs for Radiation-induced Lung Injury Radiation-induced Lung Injury | EARLY_Phase 1 | 2025-10-01 |
| Not Yet Recruiting | Study on Safety and Efficacy of UCB-MNCs for Chronic Radiation Enteritis Chronic Radiation Induced Intestinal Injury, Chronic Radiation Enteritis | EARLY_Phase 1 | 2025-10-01 |
| Recruiting | Real-Time Dynamic Imaging Study of Normal Pharyngolaryngeal Structures During Barium Swallow (GLAM-III) Barium Meal Examination | — | 2025-09-10 |
| Not Yet Recruiting | SCRT Followed by AK112 in pMMR/MSS Mid-low Rectal Cancer Rectal Cancer, Radiation, AK112 | Phase 2 | 2025-09-01 |
| Not Yet Recruiting | Irinotecan Liposomes in Total Neoadjuvant Therapy in Locally Advanced Rectal Cancer Locally Advanced Rectal Cancer | Phase 3 | 2025-07-20 |
| Recruiting | Effect of Small Double-lumen Tube on the Intubation Time of Thoracoscopic Pulmonectomy in Asian Women Women, Asian, Thoracic Surgery With One-lung Ventilation | N/A | 2025-07-15 |
| Not Yet Recruiting | a Single Arm, Phase II Multicenter Clinical Trial to Evaluate the Efficacy and Safety of the Combination Thera Cervical Cancer Stage IVA, Cervical Cancer Metastatic | Phase 2 | 2025-07-01 |
| Recruiting | Clinical Evaluation of GRAPE Model for Gastric Cancer Screening Gastric Cancer | — | 2025-05-30 |
| Completed | Effect of Trendelenburg Positioning on Anesthesia-Induced Hypotension in Elderly Patients Hypotension on Induction, Old Age | N/A | 2025-05-16 |
| Not Yet Recruiting | Zanubrutinib Plus GCVP (Obinutuzumab, Cyclophosphamide, Vindesine, Prednisolone) in Previously Untreated Folli BTK Inhibitors, Follicular Lymphoma, Immunochemotherapy | Phase 2 | 2025-05-01 |
| Not Yet Recruiting | SH-LPS System in Preoperative Planning for Liver Resection Liver Tumor; Surgery, 3D Printing, Preoperative Planning | Phase 2 / Phase 3 | 2025-04-15 |
| Not Yet Recruiting | Cerebrospinal Fluid Cytology-guided Intrathecal Chemo-holiday Therapy for EGFR-positive NSCLC Leptomeningeal M Leptomeningeal Metastases | Phase 2 | 2025-04-01 |
| Recruiting | Hepatic Arterial Infusion Chemotherapy and Immunotherapy for Hepatocellular Carcinoma Hepatocellular Carcinoma (HCC) | Phase 1 / Phase 2 | 2025-03-01 |
| Recruiting | A Study on the Efficacy and Safety of Switching Between Two Targeted Strategies, HP+Chemotherapy and HPy+Chemo Breast Cancer | — | 2025-03-01 |
| Recruiting | Rituximab-Methotrexate-Temozolomide-Thiotepa (RMTT) Regimen As First-line Therapy for PCNS DLBCL Primary Central Nervous System Lymphoma | N/A | 2025-02-14 |
| Recruiting | Phase II Trial of Albumin-Bound Paclitaxel Combined With Nedaplatin (TP) Via Hepatic Arterial Infusion for Adv Hepatic Artery Infusion, Liver Metastasis of Breast Cancer | Phase 2 | 2025-02-01 |
| Recruiting | To Investigate the Real-world Efficacy and Safety of Sacituzumab Govitecan for HER2 Negative Metastatic Breast Breast Cancer Metastatic | — | 2025-02-01 |
| Recruiting | Efficacy and Safety of Distamab Vedotin Combined With Carboplatin for Advanced Ovarian Cancer in the First Lin Ovarian Cancer, HER2 | Phase 2 | 2025-01-04 |
| Not Yet Recruiting | Sintilimab Combined With Bevacizumab and TP Chemotherapy in the Treatment of High Risk Locally-advanced NPC Locally Advanced Nasopharyngeal Carcinoma | Phase 2 | 2024-12-31 |
| Recruiting | Postoperative Analgesia Between Paravertebral Block and Epidural Block in Esophageal Surgery Pain Syndrome, Dizziness, Vomiting | N/A | 2024-12-03 |
| Recruiting | Pharmacokinetic Study of Tranexamic Acid Ovarian Neoplasm Epithelial | N/A | 2024-11-20 |
| Recruiting | RLC Followed by CR-CHOP in Elderly Patients with Newly-diagnosed DEL Double-expressor Lymphoma | Phase 2 | 2024-11-06 |
| Completed | Esketamine for Prevention of Depression After Cytoreductive Surgery in Ovarian Cancer Ovarian Cancer, Cytoreductive Surgery, Depressive Symptom | N/A | 2024-10-08 |
| Not Yet Recruiting | GEP Combined With Radiotherapy in Non-locally Treatable Recurrent NPC Nasopharynx Cancer | Phase 2 | 2024-09-30 |
| Recruiting | Different Intraoperative Blood Pressure Management on Postoperative Cognitive Function in Tumor Patients（PRECI Tumor, Stroke | N/A | 2024-09-18 |
| Not Yet Recruiting | A Study to Investigate the Efficacy and Safety of Ivonescimab Combined With Irinotecan Liposome as Second-line Extensive-stage Small-cell Lung Cancer | Phase 2 | 2024-09-01 |
| Recruiting | Study of Pomalidomide Combination with Rituximab and Anti-PD-1 Antibody （PPR） in Third or Later Line Therapy o Diffuse Large B-cell Lymphoma (DLBCL) | N/A | 2024-09-01 |
| Active Not Recruiting | Establishment of a Predictive Model for Immunotherapy Response in Pancreatic Cancer Pancreatic Cancer Non-resectable | — | 2024-09-01 |
| Recruiting | Disitamab Vedotin Plus Trastuzumab in Patients With HER2 Positive GC/GEJ Patiens HER2-positive Gastric Cancer, HER2-positive Gastroesophageal Junction Adenocarcinoma | Phase 1 / Phase 2 | 2024-09-01 |
| Recruiting | Tislelizumab Combined with Nab-Paclitaxel for First-Line Treatment of Advanced Triple-Negative Breast Cancer w Triple-negative Breast Cancer, Bone Metastases | Phase 2 | 2024-08-20 |
| Completed | Effect of Esketamine on Anxiety State in Patients Undergoing Abdominal Tumor Surgery Anxiety State, Esketamine | N/A | 2024-08-05 |
| Recruiting | Neoadjuvant ChemoRadiotherapy Followed by Immunotherapy and Surgery for Resectable Esophageal Squamous Cell Ca Esophageal Squamous Cell Carcinoma | Phase 2 | 2024-08-01 |
| Recruiting | Adebrelimab Combined With Chemotherapy and Concurrent SBRT for Neoadjuvant Treatment of Limited-stage Small Ce Efficacy and Safety of Neoadjuvant Immunotherapy for Small Cell Lung Cancer | Phase 2 | 2024-07-24 |
| Recruiting | Cadonilimab Combination Regimen as First-line Treatment for HER2-expressing GC/GEJ Patients Metastatic HER2 Positive Gastroesophageal Junction Cancer | Phase 1 / Phase 2 | 2024-07-10 |
| Recruiting | ctDNA-guided Selection of Adjuvant Chemotherapy Regimens for Elderly Colon Cancer Patients After Surgery: A Si Colon Cancer, Colon Cancer (Stage II &Amp;Amp;Amp; III) | Phase 3 | 2024-07-03 |
| Not Yet Recruiting | Multimodal Rehabilitation on Gastric Adenocarcinoma Patients Following Radical D2 Gastrectomy Gastric Cancer | Phase 2 | 2024-06-01 |
| Recruiting | Sintilimab After Concurrent Chemoradiotherapy in Elderly Patients With Esophageal Squamous Cell Carcinoma Esophageal Cancer, Chemoradiotherapy, Sintilimab | Phase 2 | 2024-06-01 |
| Not Yet Recruiting | Phase II Study of Liposomal Irinotecan for Advanced Refractory Gastric Cancer Gastric Cancer | Phase 2 | 2024-05-27 |
| Recruiting | Sequential Tegafur-gimeracil-oteracil Potassium Capsule (s-1) and Serplulimab Following Concurrent Chemoradiot Locally Advanced Inoperable Esophageal Squamous Cell Carcinoma | Phase 2 | 2024-05-20 |
| Completed | GMA-Tulip, I-gel and the LMA-Supreme (LMA-S) Devices in Airway Management (GLAM-I) Anesthesia, Airway Remodeling | N/A | 2024-04-30 |
| Not Yet Recruiting | Sintilimab Combination Therapy Plus IMRT in Nasopharyngeal Carcinoma Nasopharyngeal Carcinoma | Phase 2 | 2024-04-22 |
| Not Yet Recruiting | Adebrelimab Combined With Fluzoparib in HRD-positive HR +/HER2- Advanced Breast Cancer Female Breast Cancer Patients, Histopathologically Confirmed Advanced HR +/HER2-invasive Breast Cancer, HRD Positive Advanced Breast Cancer | Phase 2 | 2024-04-16 |
| Recruiting | Ciprofol EC50 for Inducing Loss of Consciousness in Elderly Patients Elderly Patients | Phase 4 | 2024-04-02 |
| Recruiting | A Phase II, Single-arm, Multicenter, Prospective Study of Cardunolizumab in Recurrent or Metastatic Vulvar and Vulvar and Vaginal Cancer | Phase 2 | 2024-03-22 |
| Recruiting | A Randomized, Multicenter Phase II Basket Study of Hypofractionated Radiotherapy/Stereotactic Body Radiotherap Her-2 Negative Adenocarcinoma of the Gastro-oesophageal Junction/Gastric Adenocarcinoma, Hepatocellular Carcinoma, Biliary Tract Carcinoma | N/A | 2024-03-20 |
| Not Yet Recruiting | Eribulin Combined With Sintilimab as First-line Treatment for Unresectable Locally Advanced or Metastatic HER2 Metastatic Breast Cancer | Phase 2 | 2024-03-08 |
| Unknown | Genotype-driven Weekly Irinotecan Liposomes in Combination With Capecitabine-based Neoadjuvant Chemoradiation Rectal Cancer | Phase 1 | 2024-03-03 |
| Recruiting | Adjuvant Radiotherapy for Esophageal Squamous Cell Carcinoma in the Era of Immunotherapy Adjuvant Radiotherapy | Phase 2 | 2024-03-01 |
| Suspended | SBRT Sequential Surufatinib Combined With Immunotherapy for Biliary Tract Carcinoma Biliary Tract Carcinoma | Phase 2 | 2024-02-01 |
| Recruiting | The Use of Shengmai San to Prevent Anthracycline Sequential Trastuzumab Therapy Related Cardiac Toxicity Cardiotoxicity Induced by Drug Therapy for Breast Cancer | Phase 3 | 2024-01-20 |
| Not Yet Recruiting | Clinical Study of Short-course Radiotherapy Followed by Fruquintinib Plus Sintilimab vs Bevacizumab Plus Capec CRC, Metastatic Colorectal Cancer, Metastatic Colorectal Adenocarcinoma | Phase 1 / Phase 2 | 2024-01-01 |
| Completed | Postoperative Analgesia With Liposomal Bupivacaine Versus Standard Bupivacaine Combined With Dexamethasone Liver Cancer | Phase 4 | 2023-12-15 |
| Unknown | Serplulimab for Patients With Non-small Cell Lung Cancer (NSCLC) With TPS ≥ 50%: a Prospective, Single-center, Non-small Cell Lung Cancer, PDL1 Gene Mutation | Phase 2 | 2023-12-01 |
| Not Yet Recruiting | The Efficacy and Safety of Lenvatinib Combined With Sindilimab and Nab-paclitaxel in the First-line Treatment Breast Neoplasms | Phase 1 / Phase 2 | 2023-11-30 |
| Recruiting | LCMS-Based Metabolic Analysis Explores the Effect of American Ginseng on Urine and Plasma in Healthy Individua The Impact of American Ginseng on the Metabolomics of Urine and Plasma in Healthy Individuals | N/A | 2023-11-11 |
| Unknown | Surufatinib Plus Cadonilimab in Patients With Unresectable or Metastatic Bile Duct Adenocarcinoma Bile Duct Adenocarcinoma | Phase 2 | 2023-10-30 |
| Recruiting | A Clinical Study of Sintilimab as Adjuvant Therapy in Node-positive ESCC Esophageal Squamous Cell Carcinoma | Phase 2 | 2023-10-25 |
| Recruiting | Testing the Addition of Radiation Therapy to the Immune Therapy Treatment for ES-SCLC Extensive Stage Lung Small Cell Cancer | Phase 2 | 2023-10-18 |
| Recruiting | A-RGEMOX in the Treatment of Early Relapsed/Refractory DLBCL Diffuse Large B-cell Lymphoma Recurrent, Diffuse Large B Cell Lymphoma Refractory | Phase 2 | 2023-10-01 |
| Recruiting | Gemcitabine Combined With Endostar and Envafolimab in Elderly Patients With Locally Advanced Nasopharyngeal Ca Nasopharyngeal Carcinoma | Phase 2 | 2023-09-28 |
| Unknown | 3D Printed Models for Liver Surgery Liver Cancer | Phase 1 | 2023-09-15 |
| Unknown | Radiotherapy Combined With ICIs as Treatment for LA-NSCLC After Failing Induction Immunochemotherapy Non-small Cell Lung Cancer Stage III | Phase 3 | 2023-09-15 |
| Unknown | Prospective Observational Study to Predict the Response of Biliary Tract Tumors to Immunotherapy Biliary Tract Tumor, Cholangiocarcinoma | — | 2023-09-14 |
| Unknown | A Multi-omics-based Metabolic Typing Study of Gastric Cancer Gastric Cancer, Multi-omics, Diagnosis | — | 2023-09-10 |
| Not Yet Recruiting | Fruquintinib Combined With Chemotherapy as Third-line /Third-line+ Treatment in Advanced Colorectal Cancer Advanced Colorectal Cancer | N/A | 2023-08-28 |
| Not Yet Recruiting | Cetuximab in Combination With Dabrafenib and Tislelizumab in BRAF Mutated Treatment of Advanced Colorectal Can Advanced Colorectal Cancer | N/A | 2023-08-01 |
| Unknown | Advanced Pancreatic Cancer Progression-free Survival | Phase 2 | 2023-08-01 |
| Unknown | Dalpiciclib Combination With Fulvestrant and Compound Gossyfol Acetate Tablets in Women With CDK4/6 Inhibitor- Advanced HR-positive and HER2-negative Breast Cancer; CDK4/6 Inhibitor Treatment Failed | Phase 2 | 2023-08-01 |
| Unknown | Ciprofol Sedation in Patients Undergoing Liver Cancer Percutaneous Radiofrequency Ablation Liver Cancer, Ciprofol | N/A | 2023-08-01 |
| Unknown | Icaritin Soft Capsule Combined With Lenvatinib and TACE for the Treatment of Hepatocellular Carcinoma Hepatocellular Carcinoma | Phase 2 | 2023-07-01 |
| Unknown | Combined Treatment of Treated Bile Duct Cancer Bile Duct Cancer | Phase 2 | 2023-07-01 |
| Recruiting | Lenvatinib Combined with Tislelizumab and TACE Applied As Neoadjuvant Regimen for the Patients of CNLC Stage I Hepatocellular Carcinoma, Lenvatinib, Tislelizumab | Phase 2 | 2023-07-01 |
| Unknown | A Study to Investigate the Efficacy and Safety of Tislelizumab Combined With Anlotinib as Maintenance Therapy Extensive Stage Small Cell Lung Cancer | Phase 2 | 2023-05-15 |
| Recruiting | GOT Applied As Neoadjuvant Regimen for Patients of Resectable ICC with High-risk Factors of Recurrence Intrahepatic Cholangiocarcinoma | Phase 2 | 2023-05-05 |
| Recruiting | Sequential AG and mFOLFOX Combined With Serplulimab Injection and Bevacizumab Injection in Untreated Advanced Non-Resectable Pancreas Carcinoma | Phase 2 | 2023-05-01 |
| Recruiting | Disitamab Vedotin Plus Cadonilimab in Patients With HER2 Mutant Advanced or Metastatic Bile Duct Adenocarcinom Bile Duct Adenocarcinoma Non-Resectable, HER2 Gene Mutation | Phase 2 | 2023-05-01 |
| Recruiting | Neoadjuvant Chemotherapy Plus Toripalimab in Patients With Locoregionally Advanced Nasopharyngeal Carcinoma Nasopharyngeal Carcinoma | Phase 2 | 2023-04-03 |
| Unknown | Multi-omics Study of Tongue Coating in Malignant Tumors of Digestive Tract Malignant Tumors of Digestive Tract | — | 2023-04-01 |
| Completed | The Formulation of Compound Phellinus Igniarius Decoction on Radiation Pneumonitis Radiation Pneumonitis | Phase 1 | 2023-03-22 |
| Unknown | Mechanism of Gastric Signet Ring Cell Carcinoma Based on Microproteomics Gastric Cancer, Signet Ring Cell Carcinoma | — | 2023-03-02 |
| Recruiting | Combined Screening for Gastrointestinal Tumors Gastrointestinal Tumors | — | 2023-03-01 |
| Unknown | Sintilimab in Combination With S-1/Oxaliplatin With Nab-paclitaxel Intraperitoneal Infusion for Untreated Adva Gastric Cancer, Peritoneal Metastases, Ascites, Malignant | Phase 2 | 2023-03-01 |
| Recruiting | Pyrotinib Combined With Dalpiciclib Combined With Letrozole in ER-positive and HER2-positive Advanced Breast C Breast Cancer | Phase 2 | 2023-02-01 |
| Unknown | A Companion Diagnostic Study to Develop Circulating Exosomes as Predictive Biomarkers for the Response to Immu Renal Cell Carcinoma | — | 2023-01-01 |
| Recruiting | PCI and Brain MRI Follow-up vs Brain MRI Follow-up Alone in Limited-stage SCLC Patients Small Cell Lung Cancer Limited Stage | N/A | 2023-01-01 |
| Unknown | Camrelizumab Combined With Irinotecan or Albumin Paclitaxel for Second-line Treatment of Advanced Gastric Canc Second Line Treatment of Gastric Cancer | Phase 2 | 2022-12-01 |
| Unknown | A Phase III Trial of Anus-preservation in Low Rectal Adenocarcinoma Based on MMR/MSI Status Toripalimab, Radiation | Phase 3 | 2022-11-01 |
| Unknown | Dynamic Contrast-enhanced MRI Combined With IVIM-DWI for Early Prediction of Chemosensitivity in Liver MBC Metastatic Breast Cancer in the Liver | — | 2022-09-16 |
| Recruiting | SBRT Combined With Chemotherapy and Tislelizumab in Metastatic NPC Advanced Nasopharyngeal Carcinoma | Phase 2 | 2022-09-15 |
| Unknown | Phase II Study of Niraparib in Metastatic TNBC Patients With Homologous Recombination Deficiency Homologous Recombination Deficiency, Triple Negative Breast Cancer | Phase 2 | 2022-09-01 |
| Unknown | TRT for ES-SCLC After First Line Treatment With Immune Checkpoint Inhibitors SCLC,Extensive Stage | Phase 2 | 2022-09-01 |
| Not Yet Recruiting | Effect of Zoledronic Acid Treatment on Bone-related Events in Breast Cancer Patients With Bone Metastases: a P Histologically Confirmed Breast Cancer ,Diagnosis of Bone Metastasis | — | 2022-08-30 |
| Unknown | Oncolytic Adenovirus Combined With PD-1 Inhibitor in Patients With Non-muscle-invasive Bladder Cancer Bladder Cancer | Phase 2 | 2022-08-26 |
| Unknown | A Study to Explore Pamiparib Treatment in Epithelial Ovarian Cancer After Prior PARP Inhibitor Exposure Epithelial Ovarian Cancer | Phase 2 | 2022-08-16 |
| Unknown | A Single-Arm Phase II Exploratory Clinical Study of Pemigatinib in the Treatment of Advanced Gastrointestinal Gastrointestinal Cancer | Phase 2 | 2022-08-10 |
| Recruiting | Watch and Wait for NeoAdjuvant Concurrent Radiochemotherapy Combined With Camrelizumab in Patients With Resect Esophageal Squamous Cell Carcinoma | Phase 2 | 2022-08-03 |
| Recruiting | Radiotherapy Combined With Endostatin and Capecitabine for NPC Nasopharyngeal Carcinoma | Phase 2 | 2022-08-01 |
| Unknown | XPO-1 in Combination With RCHOP for DH/TH Lymphoma Double Hit Lymphoma, Triple Hit Lymphoma | Phase 2 | 2022-08-01 |
| Recruiting | ZR2 Sequential Immunochemotherapy for Newly Treated MCL Rituximab, Lenalidomide, Zebutinib ，Mantle Cell Lymphoma | Phase 2 | 2022-08-01 |
| Completed | Transversus Thoracic Muscle Plane Combined With Pectoral Nerves Block for Breast Cancer Surgery Breast Cancer | N/A | 2022-07-12 |
| Unknown | DLCS for Predicting Neoadjuvant Chemotherapy Response Gastric Cancer, CT Images, Deep Learning | — | 2022-07-01 |
| Unknown | A Clinical Study to Explore the Efficacy and Safety of Tislelizumab in Combination With Bevacizumab and Chemot Cervical Cancer | Phase 2 | 2022-06-30 |
| Unknown | A Retrospective Study of Immunotherapy in Conversion Therapy of Unresectable Gastric Cancer Unresectable Gastric Cancer | — | 2022-06-01 |
| Unknown | SBRT for Oligoprogressive NSCLC After First Line Treatment With Immune Checkpoint Inhibitors NSCLC Stage IV | Phase 2 | 2022-05-01 |
| Unknown | Phase II Clinical Study of Camrelizumab Combined With Chemotherapy or Anlotinib in Advanced Esophageal Squamou Stage IV Esophagus Squamous Cell Carcinoma | Phase 2 | 2022-04-15 |
| Completed | The 90% Effective Flow of High Flow Nasal Oxygenation (HFNO) During Sedated Bronchoscopy Hypoxia | N/A | 2022-04-01 |
| Unknown | A Study to Investigate the Efficacy and Safety of Tislelizumab Combined With Sitravatinib as Maintenance Thera Lung Cancer, Small Cell | Phase 2 | 2022-03-17 |
| Recruiting | Efficacy and Safety of Inetetamab Combined With Pyrotinib and Vinorelbine in ABC HER2-positive Advanced Breast Cancer | — | 2022-03-16 |
| Unknown | H101 Combined With Camrelizumab for Recurrent Cervical Cancer Uterine Cervical Neoplasms, Oncolytic Virotherapy, Camrelizumab | Phase 2 | 2022-03-01 |
| Recruiting | Retrospective Study of Brachytherapy Brachytherapy, Uterine Cervical Neoplasms, Uterine Neoplasms | — | 2022-02-20 |
| Completed | IT-TT as an Effective and Well-Tolerated Strategy for CNS Prop in High-Risk DLBCL: a Prospective Ph II Study Diffuse Large B-Cell Lymphoma (DLBCL), Intrathecal Chemotherapy | Phase 2 | 2022-02-01 |
| Unknown | Tirelizumab in Combination With Chemoradiation in Patients With Unresectable Gastric Cancer or Gastroesophagea Locally Advanced Gastric Cancer | Phase 2 | 2022-01-01 |
| Completed | HFNC and Hypoxia/Desaturation During Radiofrequency Ablation Under Moderate Sedation: A Randomized Clinical Tr Propofol, Hypoxia, Sedation Complication | N/A | 2022-01-01 |
| Recruiting | UGT1A1-Based Irinotecan Therapy for Locally Advanced Rectal Cancer Rectal Cancer Stage III | Phase 4 | 2022-01-01 |
| Unknown | A Multicenter, Randomized Controlled, Phase II Clinical Study of First-line Chemotherapy and Camrelizumab With Esophageal Cancer | Phase 2 | 2021-12-31 |
| Unknown | Phase II Study of Fruquintinib Combined With Sintilimab and TACE for Inoperable Primary Hepatocellular Carcino Hepatocellular Carcinoma | Phase 2 | 2021-11-23 |
| Recruiting | Immune Score Based Radiomics in Nasopharyngeal Carcinoma Nasopharyngeal Carcinoma | — | 2021-11-05 |
| Completed | PTC Guiding Neoadjuvant Treatment in Breast Cancer Pathological Conditions, Signs and Symptoms | Phase 2 | 2021-11-01 |
| Unknown | ZR2 Followed by Immunochemotherapy in Elderly Patients With Newly-diagnosed DLBCL Diffuse Large B Cell Lymphoma | Phase 2 | 2021-10-01 |
| Unknown | Idarubicin vs. Epirubicin TACE in the Treatment of Hepatocellular Carcinoma Hepatocellular Carcinoma | N/A | 2021-10-01 |
| Unknown | Radiotherapy Combined With Tislelizumab and Irinotecan in MSS/pMMR Recurrence and Metastatic Colorectal Cancer Mismatch Repair-proficient, Colorectal Cancer Metastatic, Microsatellite Stable | Phase 2 | 2021-10-01 |
| Unknown | Dendrobium Huoshanense Suppository in Rectal Cancer Locally Advanced Rectal Cancer | Phase 3 | 2021-09-07 |
| Recruiting | The Efficacy and Safety of Anlotinib Combined With Fulvestrant in Patients With Advanced Breast Cancer Breast Neoplasm Female | Phase 2 | 2021-09-01 |
| Unknown | Early Detection of Gastric Cancer Using Plasma Cell-free DNA Fragmentomics Early Gastric Cancer | — | 2021-09-01 |
| Recruiting | Para-aortic Prophylactic Irradiation for Locally Advanced Cervical Cancer Cervical Cancer | Phase 3 | 2021-08-02 |
| Unknown | HIPEC Combined With Camrelizumab, Paclitaxel and S-1 for Conversion Therapy in Patients With Advanced Gastric Gastric Cancer, HIPEC, Anti-PD-1 Antibody Camrelizumab (SHR-1210), Chemotherapy and Surgery | N/A | 2021-07-31 |
| Unknown | A Phase II Study of Sintilimab Combined With Anlotinib in Treatment of ED-SCLC Small Cell Lung Cancer Extensive Stage | Phase 2 | 2021-07-26 |
| Active Not Recruiting | Almonertinib as First-line Treatment in Patients With EGFR Mutations Positive in Advanced NSCLC With Brain Met Lung Cancer | Phase 2 | 2021-07-09 |
| Unknown | Lenvatinib Plus HAIC of Modified FOLFOX Regime vs Lenvatinib Plus HAIC of ROX Regime in Patients With Advanced Hepatocellular Carcinoma Stage IIIa | EARLY_Phase 1 | 2021-07-01 |
| Unknown | RecurIndex Predicts Risk of Recurrence in Early-stage Luminal Breast Cancer Breast Cancer, Recurrence | — | 2021-07-01 |
| Recruiting | Development of Novel Gastric Cancer Screening and Diagnosis Technologies Using Tongue Imaging and Study of Ton Gastric Cancer, Tongue Images, Diagnosis | — | 2021-06-01 |
| Unknown | A Prospective Study of PD-1 Inhibitor Combined With ICE in the Treatment of Relapsed/Refractory Gray Area Lymp Gray Zone Lymphoma, Relapse/Recurrence, Chemotherapy Effect | Phase 2 | 2021-05-01 |
| Completed | Efficacy of Everolimus-containing Chemotherapy in HER2- mBC Patients With PI3K/AKT/mTOR Mutations Study Breast Cancer, PI3K/AKT/mTOR Pathway Mutation, Everolimus | — | 2021-05-01 |
| Unknown | Tumor Response Time of Palbociclib in Combination With AI in Real-world Chinese Patients Breast Neoplasms | Phase 2 | 2021-04-22 |
| Recruiting | Preliminary Experimental Study on Key Technologies for Early Screening of Gastric Cancer Gastric Cancer, Healthy | — | 2021-03-01 |
| Unknown | Neoadjuvant Study of Navelbine in Patients With HER2 Positive Breast Cancer Breast Cancer | Phase 3 | 2021-03-01 |
| Completed | A Trial of Sintilimab Plus Anlotinib For Metastatic NSCLC After First-Line PD-1 Inhibitor NSCLC | Phase 2 | 2021-03-01 |
| Unknown | A Study of Diarrhea and Intestinal Flora Changes Caused by Pyrotinib in Breast Cancer Breast Cancer | — | 2021-01-18 |
| Completed | Clinical Application Value of Remazolam Combined With Sugammadex Sodium in Anesthesia for Endotracheal Surgery Endobronchial Metastases, Bronchoesophageal Fistula, General Anesthetic Drug Adverse Reaction | Phase 4 | 2021-01-04 |
| Unknown | Cipterbin Combined With Vinorelbine in the Treatment of HER2-positive MBC Metastatic Breast Cancer | Phase 4 | 2021-01-04 |
| Unknown | Study of Anlotinib With Chemoradiation for Patients With Locally Advanced Nasopharyngeal Carcinoma Nasopharyngeal Carcinoma | Phase 2 | 2021-01-01 |
| Completed | Real World Study of Bone Metastases in Patients with Advanced Breast Cancer Breast Cancer Metastatic | — | 2021-01-01 |
| Completed | Anterior Quadratus Lumborum Block at the Lateral Supra-arcuate Ligament for Analgesia After Open Liver Surgery Liver Surgery | N/A | 2020-12-17 |
| Completed | Effect of Propofol and Desflurane on Nucleic Acid of Liver Circulating Tumor Hepatocellular Carcinoma, Desflurane Adverse Reaction, Propofol Adverse Reaction | Phase 2 | 2020-12-01 |
| Unknown | Neoadjuvant Short-course Radiotherapy Followed by the Combination of Immunotherapy and Chemotherapy in Locally Locally Advanced Rectal Cancer | Phase 2 | 2020-12-01 |
| Unknown | Anlotinib to Malignant Brainstem Glioma Malignant Brain Stem Tumor, Glioma | Phase 2 | 2020-11-24 |
| Unknown | TACE Combined With Lenvatinib for Unresectable Hepatocellular Carcinoma (Prolong) Carcinoma, Hepatocellular | — | 2020-09-30 |
| Unknown | Durvalumab Combined With Chemotherapy and Stereotactic Body Radiotherapy (SBRT) in Patients With Oligometastat Carcinoma, Non-Small-Cell Lung | Phase 2 | 2020-09-30 |
| Unknown | A Clinical Study Of Camrelizumab With Or Without Radiotherapy In The Treatment Of Esophageal Cancer Esophageal Cancer | Phase 2 | 2020-08-31 |
| Unknown | Camrelizumab in Combination With Neoadjuvant Chemotherapy for Resectable Thoracic Esophageal Squamous Cell Car Esophageal Squamous Cell Carcinoma | Phase 1 / Phase 2 | 2020-08-11 |
| Unknown | A Clinical Study of Exploring Camrelizumab in the Treatment of Colorectal Mucinous Adenocarcinoma(MAC) Colorectal Cancer | Phase 1 / Phase 2 | 2020-07-01 |
| Unknown | Single Cell Sequencing Analysis of Thymoma Thymoma | — | 2020-06-06 |
| Unknown | The Combination of Camrelizumab and Apatinib as Second-line Therapy for Advanced Pancreatic Carcinoma Pancreatic Cancer | Phase 2 | 2020-06-01 |
| Unknown | Preliminary Efficacy Analysis of Cheng's Giraffe Reconstruction After Proximal Gastrectomy Gastric Cancer, Reflux Esophagitis | N/A | 2020-06-01 |
| Completed | Establishment of Tongue Image Database and Machine Learning Model for Malignant Tumors Diagnosis Malignant Tumor | — | 2020-05-01 |
| Unknown | Rituximab Combined With Chidamide and Lenalidomide for r/r AITL Angioimmunoblastic T-cell Lymphoma, Chemotherapy Effect, Chemotherapeutic Toxicity | N/A | 2020-03-13 |
| Unknown | Nab-paclitaxel Combined With S-1 as Adjuvant Chemotherapy for Stage Ⅲ Gastric Cancer Stomach Cancer | Phase 3 | 2020-03-01 |
| Unknown | Chemoradiotherapy With or Without Sintilimab in Limited-stage SCLC Small Cell Lung Cancer Limited Stage | Phase 2 | 2020-01-01 |
| Unknown | Anlotinib in Combination With PD1 With Gemcitabine Plus(+)Cisplatin for Unresectable or Metastatic Biliary Tra Biliary Tract Cancer | Phase 2 | 2020-01-01 |
| Unknown | Camrelizumab Combined With Local Treatment in NSCLC Patients With BM NSCLC Stage IV, Brain Metastases, Immunotherapy | Phase 2 | 2020-01-01 |
| Unknown | Toripalimab Combined With Apatinib Mesylate for the Treatment of Gastric Adenocarcinoma in a Prospective Rando Gastric Adenocarcinoma | Phase 2 | 2019-11-29 |
| Unknown | Endostar Combined With Concurrent Radiochemotherapy for Treatment of Unresectable Stage III NSCLC Unresectable Stage III NSCLC | — | 2019-11-25 |
| Unknown | Recurrence Score-guiding Chemotherapy in Non-pCR HR Positive HER2 Negative Breast Cancer After Neoadjuvant The Breast Cancer | Phase 2 | 2019-11-01 |
| Unknown | Clinical Study on the First-line Treatment of Advanced Biliary System Tumors With Tripley Monoclonal Antibody Advanced Biliary Tract Tumors | Phase 2 | 2019-10-14 |
| Suspended | A Study of Toripalimab Combined With Concurrent Chemoradiotherapy for Locally Advanced Esophageal Squamous Cel Esophageal Squamous Cell Carcinoma | Phase 2 | 2019-09-07 |
| Unknown | TACE Combined With Anlotinib Treatment of Middle-advanced Hepatocellular Carcinoma (HCC) Patients Carcinoma, Hepatocellular | Phase 2 | 2019-08-30 |
| Unknown | Decitabine Combined With Oxaliplatin in Patients With Advanced Renal Cell Carcinoma Metastatic Renal Cell Carcinoma | Phase 2 | 2019-08-15 |
| Unknown | A Study of Bortezomib Combined With CHEP in Peripheral T Cell Lymphoma Peripheral T Cell Lymphoma | Phase 2 | 2019-08-12 |
| Unknown | CCRT Combined With Endostar for the Treatment of Locally Advanced Cervical Cancer Cervical Cancer | Phase 2 | 2019-08-01 |
| Completed | Sintilimab Combined With Anlotinib in Advanced NSCLC With EGFR Uncommon Mutations Lung Cancer | Phase 2 | 2019-08-01 |
| Unknown | Neoadjuvant Study of Pyrotinib in Patients With HER2 Positive Breast Cancer Breast Cancer, Neoplasm, Breast, Breast Diseases | N/A | 2019-08-01 |
| Unknown | Correlation Between Molecular Typing and Neoadjuvant Chemotherapy in Breast Cancer Patients Based on Mammaprin Evaluation of the Value of Mammaprint Test Gene Variation in the Prediction of Neoadjuvant Chemotherapy for Breast Cancer | — | 2019-05-14 |
| Unknown | A Study of Sintilimab Plus Chemoradiation Before Surgery for Esophageal Cancer Esophageal Squamous Cell Carcinoma | EARLY_Phase 1 | 2019-05-01 |
| Completed | Pilot Study of Anlotinib With STUPP Regimen for Patients With Newly Diagnosed Glioblastoma Glioblastoma | Phase 1 / Phase 2 | 2019-03-19 |
| Unknown | Adujvant CT+CRT vs Adujvant CT After D2 Resection for Locally Advanced Proximal Gastric Adenocarcinoma Gastric Adenocarcinoma | Phase 3 | 2019-03-11 |
| Unknown | Pyrotinib Combined With Docetaxel in the First-line Treatment of HER2-positive MBC Metastatic Breast Cancer | Phase 2 | 2019-03-01 |
| Unknown | Capecitabine in the Treatment of Breast Cancer With Low-hormone Receptor Expression After Neoadjuvant Chemothe Breast Cancer | N/A | 2019-02-01 |
| Unknown | Prophylactic Use of PEG-rhG-CSF in Medium-high Risk of FN in Chemotherapy of Breast Cancer Febrile Neutropenia | — | 2019-01-20 |
| Unknown | Tegio Consolidation Therapy for NPC Patients With High Risk of Metastasis Nasopharyngeal Carcinoma | Phase 2 | 2018-12-14 |
| Unknown | The Combination of Palbociclib With ddEC-P as Neoadjuvant Therapy in Triple Negative Breast Cancer Breast Cancer, Breast Diseases, Breast Neoplasms | N/A | 2018-12-01 |
| Unknown | The Efficacy and Safety of Abraxane Combined With Epirubicin as Neoadjuvant Chemotherapy in Breast Cancer Breast Cancer | N/A | 2018-12-01 |
| Unknown | Abraxane Combined With Xeloda as Neo-Adjuvant Chemotherapy in Early Breast Cancer Breast Cancer | N/A | 2018-12-01 |
| Unknown | A Prospective Validation Cohort Study of a Prediction System on nSLN Metastasis in Early Breast Cancer Lymph Node Metastases, Breast Cancer, Predictive Cancer Model | N/A | 2018-10-15 |
| Unknown | Interleukin-11 Can Prevent and Treat of Radioactive Oral Mucitis Nasopharyngeal Carcinoma | Phase 3 | 2018-10-01 |
| Unknown | A Prospective Randomized Trial of Capecitabine Treatment in Patients With HNSCC Head and Neck Neoplasms | Phase 2 | 2018-09-10 |
| Unknown | TOMO Versus IMRT in Nasopharyngeal Carcinoma Patients Nasopharyngeal Carcinoma | — | 2018-07-01 |
| Completed | The Role of Clean Intermittent Catheterization in Patients Undergoing Radiotherapy After Radical Hysterectomy Uterine Cervical Neoplasms | N/A | 2018-07-01 |
| Unknown | Individualized Pharmaceutical-care in Outpatients With Cancer Pain Cancer Pain | N/A | 2018-06-30 |
| Unknown | Individualized Pharmaceutical-care for Inpatients With Cancer Pain Cancer Pain | N/A | 2018-06-30 |
| Unknown | PET/MR in Locally Advanced Nasopharyngeal Carcinoma Nasopharyngeal Carcinoma, PET/MR | N/A | 2018-06-01 |
| Unknown | A Prospective Study Comparing Two Radiotherapy Dose/Fraction and Omitting CTVs of the Primary Tumor in Limited Small Cell Lung Cancer Limited Stage | Phase 2 | 2018-05-01 |
| Completed | Different Radiation Dose of Neoadjuvant Chemoradiation for Resectable Thoracic Esophageal Squamous Carcinoma Esophageal Carcinoma, Neoadjuvant Chemoradiotherapy, Surgery | N/A | 2018-02-22 |
| Unknown | Hippocampus Avoidance During Intensity Modulated Radiotherapy for T4 Nasopharyngeal Carcinoma Patients Nasopharyngeal Carcinoma | — | 2018-01-01 |
| Unknown | Application of Circulating Tumor DNA Test in the Diagnosis and Treatment of Patients With Advanced Rectal Canc Rectal Neoplasms, Neoadjuvant Therapy, Circulating Tumor DNA | — | 2017-07-19 |
| Unknown | Apatinib in Treating Patients With Recurrent or Metastatic Nasopharyngeal Carcinoma (NPC) Nasopharyngeal Carcinoma | Phase 2 | 2017-07-01 |
| Unknown | Chemotherapy Plus Radiation Therapy in Treating Patients With Primary Stage IVB Cervical Cancer Cervical Cancer Stage IVB | N/A | 2017-05-05 |
| Unknown | Oligo-metastases NPC Patients Received Radiation for Primary Tumors and Treatments for Metastatic Lesions Nasopharyngeal Cancer, Neoplasm Metastasis | Phase 2 | 2017-04-14 |
| Completed | Radiation Plus Concurrent Nimotuzumab in Elderly Patients With Locoregionally Advanced Nasopharyngeal Carcinom Nasopharyngeal Carcinoma | Phase 2 | 2017-03-13 |
| Completed | Remifemin Preventing the Climacteric Symptoms in Breast Cancer Effect of Drugs, Safety Issues | Phase 2 | 2017-01-04 |
| Completed | The Effects of Hemodilution Methods in Patients Undergoing Primary Debulking Gynaecological Surgery Ovarian Neoplasm Epithelial | N/A | 2017-01-01 |
| Unknown | Concurrent Chemotherapy for Elderly Patients With Locoregionally Advanced Nasopharyngeal Carcinoma Nasopharyngeal Carcinoma | Phase 2 | 2017-01-01 |
| Unknown | Induction Chemotherapy Followed by Radiotherapy Alone or Concurrent Chemoradiotherapy in Nasopharyngeal Carcin Locally Advanced Nasopharyngeal Carcinoma | Phase 3 | 2016-12-01 |
| Unknown | Monosialoganglioside Ganglioside in Cerebral Radiation Necrosis Cerebral Radiation Necrosis | Phase 2 | 2016-12-01 |
| Unknown | A Research About Nutrition Impact for Local Advanced Nasopharyngeal Carcinoma Patients Malignant Neoplasm of Nasopharynx | Phase 4 | 2016-11-01 |
| Completed | Whether Dexmedetomidine Can Improve the Prognosis of Elderly Patients With Postoperative Cognitive Dysfunction Postoperative Cognitive Dysfunction, Postoperative Delirium | Phase 4 | 2016-11-01 |
| Unknown | Memory and MRI Changes With Hippocampus Avoidance Prophylactic Cranial Irradiation(HA-PCI) for Small Cell Lung Small Cell Lung Cancer | Phase 2 | 2016-10-01 |
| Unknown | Predictive Factors of Acute Oral Mucositis Induced by Chemo-radiotherapy for Local Advanced Nasopharyngeal Car Nasopharyngeal Neoplasms, Stomatitis | — | 2016-10-01 |
| Unknown | Predictor Analysis of Acute Radiation Oral Mucositis in NPC Patients Treated With IMRT/TOMO Combined Chemother Nasopharyngeal Carcinoma | — | 2016-09-01 |
| Unknown | A Phase II Trial of S-1 as Maintenance Treatment After Gemcitabine Plus Cisplatin Regimen Chemotherapy in Pati Nasopharyngeal Carcinoma | Phase 2 | 2016-08-01 |
| Unknown | Endostar in Combination With Chemotherapy in HER-2 Negative Advanced Breast Cancer Breast Cancer | Phase 2 | 2016-06-30 |
| Completed | Whether Opioids Are Factor That Induced POD? Postoperative Delirium | N/A | 2016-06-25 |
| Completed | S-1 Concurrent With Radiotherapy Versus Radiotherapy for Elderly Patients With Esophageal Cancer Esophageal Cancer, Chemoradiation | Phase 3 | 2016-06-01 |
| Unknown | Acquired Resistant Mechanism of the First-generation EGFR TKIs Non-small Cell Lung Cancer, Aquired Resistance, EGFR TKIs | — | 2016-06-01 |
| Unknown | Aromatase Inhibitors Plus Chemotherapy vs Chemotherapy as Neoadjuvant Treatment in Postmenopausal HR(+) Breast Neoadjuvant Therapy | Phase 3 | 2016-05-01 |
| Unknown | Treatment Patients With Pulmonary Metastasis of Liver Cancer With Apatinib Combination With TACE: a Clinical S Hepatocellular Carcinoma, Pulmonary Metastasis | Phase 2 / Phase 3 | 2016-03-01 |
| Unknown | Apatinib in Combination With S-1 as Second-Line Treatment in Patients With Advanced Gastric Cancer Gastric Cancer | Phase 1 | 2016-02-23 |
| Unknown | Trial of Hypofractionated Intensity Modulated Radiation Therapy With Temozolomide and Granulocyte-macrophage C Glioblastoma Multiforme | Phase 2 | 2016-01-01 |
| Unknown | Capecitabine or Endocrinotherapy as a Maintenance Therapy Regimen at Least 2nd Line in Hormone Receptor Positi Breast Cancer | Phase 2 | 2016-01-01 |
| Unknown | Docetaxel 2-weeks Regimen in the Treatment of HER2 Negative Metastatic Breast Cancer Breast Cancer | Phase 2 | 2015-12-20 |
| Completed | DEB-TACE Treatment in 367 Liver Cancer Patients Liver Cancer | — | 2015-11-12 |
| Unknown | Thalidomide Plus Chemotherapy Versus Chemotherapy Alone for Advanced Breast Cancer Metastatic Breast Cancer | Phase 2 | 2015-10-01 |
| Unknown | HIPEC, Intravenous Chemotherapy and Surgery for the Treatment of Advanced GC With Peritoneal Metastasis Gastric Cancer | Phase 2 | 2015-09-01 |
| Unknown | Comparison of Lobectomy and Segmentectomy for cT1aN0M0 Peripheral NSCLC Non-small Cell Lung Cancer | Phase 3 | 2015-07-01 |
| Unknown | A Phase III Trail of Adjuvant Chemoradiotherapy Versus Adjuvant Radiotherapy in Esophageal Squamous Cell Carci Esophageal Cancer | Phase 3 | 2015-05-01 |
| Completed | CK19 Combined With Contrast-enhanced Ultrasound: a Prediction System on Axillary Lymph Node Metastasis in Brea Lymph Node, Breastcancer | — | 2015-04-01 |
| Unknown | Temozolomide and Concomitant Whole Brain Radiotherapy in NSCLC Patients With Brain Metastases NSCLC | Phase 1 / Phase 2 | 2015-04-01 |
| Unknown | Endostatin in Combination With Chemotherapy for Metastatic Nasopharyngeal Carcinoma Effects of Chemotherapy, Stage IVC Nasopharyngeal Carcinoma | Phase 3 | 2013-08-01 |
| Unknown | Comparable Study of Different Radiation Dose in Esophageal Carcinoma Esophageal Carcinoma | Phase 3 | 2013-08-01 |
| Unknown | Nimotuzumab in Combination With Chemoradiation in Patients With Locally Advanced Rectal Cancer Locally Advanced Rectal Cancer | Phase 2 | 2013-04-01 |
| Unknown | Phase II Trial of Regimen for Stage III (N2) NSCLC Using Induction Treatment Followed by Resection Non-small Cell Lung Cancer Stage IIIA | Phase 2 | 2013-03-01 |
| Unknown | Endostar Combined With mFOLFOX6 for First-line Treatment of Metastatic Colorectal Cancer Metastatic Colorectal Cancer | Phase 2 | 2013-01-01 |
| Unknown | A Multicenter, Randomized Clinical Trail Evaluate Effectiveness and Security of Capecitabine or Endocrinothera Breast Cancer | N/A | 2013-01-01 |
| Completed | Recombinant Human Endostatin Continued Pumping Into Vein Combining With CCRT in Unresectable Stage III NSCLC Stage III Non-small-Cell Lung Cancer | Phase 1 / Phase 2 | 2012-11-01 |
| Unknown | Study of Nimotuzumab in Combination With Neoadjuvant Chemotherapy for Resectable Esophageal Squamous Cell Carc Esophageal Squamous Cell Carcinoma Resectable | Phase 2 | 2012-09-01 |
| Unknown | Phase II Trial of Double Dose of Icotinib in Treating Brain Metastases From Non-small Cell Lung Cancer Brain Metastases, Non-small Cell Lung Cancer | Phase 2 | 2012-08-01 |
| Unknown | Study of Relationship Between UGT1A1 Gene Polymorphism and Toxicity and Efficacy of Irinotecan in Small Cell L Small Cell Carcinoma of Lung | Phase 2 | 2012-06-01 |
| Unknown | Endostar Combination With Chemotherapy for the Metastatic Nasopharyngeal Carcinoma Nasopharyngeal Carcinoma | Phase 2 | 2012-05-01 |
| Unknown | Efficacy Study of Neoadjuvant Chemotherapy With Chemoradiation Therapy for Nasopharyngeal Carcinoma Chemoradiation, Nasopharyngeal Carcinoma | Phase 3 | 2012-04-01 |
| Completed | Preoperative Systemic Therapy vs Upfront Surgery in HER2 Positive Early Breast Cancer Breast Cancer, HER2, Preoperative Systemic Treatment | — | 2012-01-01 |
| Unknown | D2 and D2+ Radical Surgery for the Treatment of Advanced Distal Gastric Cancer Gastric Cancer | Phase 2 | 2012-01-01 |
| Completed | Icotinib Combined With Whole Brain Radiotherapy in Treating Multiple Brain Metastases From Non-Small Cell Lung Lung Cancer, Metastatic Cancer | Phase 2 | 2012-01-01 |
| Unknown | Neoadjuvant Versus Adjuvant Therapy in Treating Resectable Thoracic Esophageal Cancer Esophageal Cancer | Phase 2 | 2011-10-01 |
| Unknown | Exploratory Study on the S-1 + Paclitaxel Chemotherapy for Unresectable Gastric Cancer Surgically-Created Resection Cavity, Drug Safety | Phase 2 | 2011-09-01 |
| Unknown | Peri-operative Chemotherapy With ECX or XP in the Treatment of Advanced Gastric Cancer Gastric Cancer | Phase 2 | 2011-01-01 |
| Completed | Neoadjuvant Chemotherapy With Nab-paclitaxel Plus Cisplatin for Stage Ⅱ-Ⅲ Esophageal Cancer Patients Esophageal Squamous Cell Carcinoma | Phase 2 | 2011-01-01 |
| Unknown | Gefitinib Combined With Radiotherapy in Elderly Patients With Esophageal Cancer Esophageal Cancer | Phase 2 | 2010-12-01 |
| Unknown | Prophylactic Cranial Irradiation in Erlotinib/Gefitinib-responders With Non-small Cell Lung Cancer (NSCLC) (RT Non-small Cell Lung Cancer | Phase 3 | 2010-06-01 |
| Completed | S-1 and Radiotherapy in Elderly Patients With Esophageal Cancer Esophageal Cancer | Phase 1 | 2010-02-01 |
| Completed | S-1 Plus Nedaplatin With Concurrent Radiotherapy for Advanced Esophageal Cancer Esophageal Cancer | Phase 1 | 2010-01-01 |
| Unknown | Erlotinib Combined With Radiotherapy in Patients With Non-resectable Locally Advanced Non-small Cell Lung Canc Non-small Cell Lung Cancer | Phase 2 | 2010-01-01 |
| Unknown | Concurrent Endostar, Paclitaxel/Carboplatin and Radiotherapy for Locally Advanced Non-small Cell Lung (RT0902) Non-small Cell Lung Cancer | Phase 2 | 2009-10-01 |
| Completed | Analysis of Driver Gene Mutation in Early Stage Non-small Cell Lung Cancer Non-small Cell Lung Cancer | — | 2009-01-01 |
| Unknown | A Study of Pemetrexed Plus Carboplatin Combined With Radiation in Patients With Inoperable Locally Advanced No Non-Small Cell Lung Cancer | Phase 2 | 2008-07-01 |
| Completed | Zoladex Plus Tamoxifen in Breast Cancer Mammography, Estrogen, Lipemia | N/A | 2008-06-01 |
| Unknown | A Prospective Randomized Study Comparing the Target Volume for Limited-stage Small Cell Lung Cancer Carcinoma of Lung, Small Cell, Limited Stage | Phase 2 / Phase 3 | 2002-06-01 |